Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Goldin

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Leukemia & Lymphoma|November 17, 2006
Case 31: Eosinophilia and pruritusV Jayakar, R D Goldin, Barbara J Bain
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|April 9, 2005
Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severityN J Sebire, R D Goldin, L Regan
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 15, 1989
Serum F protein: a new sensitive and specific test of hepatocellular damageG R Foster, R D Goldin, D B Oliveira
Journal of Clinical Pathology|March 28, 1998
A solitary benign lymphoid polyp of the rectum in a 51 year old womanJ Lloyd, A Darzi, J Teare, et al.
Journal of Clinical Pathology|October 1, 1996
Hepatitis C and bile duct lossR D Goldin, N K Patel, H C Thomas
Immunology|October 1, 1985
Quantitative relationship between T3 and the T-cell antigen receptor on a human leukaemic lineR D Goldin, R A Boulton, A W Boylston
Hepatology (Baltimore, Md.)|January 13, 1998
Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosisG R Foster, R D Goldin, H C Thomas
Histopathology|October 2, 2007
Structuring associated with epithelial inclusion cysts following stapled intestinal anastomosisC B B Lim, A Darzi, R D Goldin
European Journal of Immunology|March 1, 1984
A human T cell tumor which expresses the putative T cell antigen receptorA W Boylston, R D Goldin, C S Moore
Hepatology (Baltimore, Md.)|April 16, 1998
Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative StudyG C Farrell, B R Bacon, R D Goldin
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|November 17, 2006
Case 31: Eosinophilia and pruritusV Jayakar, R D Goldin, Barbara J Bain
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|April 9, 2005
Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severityN J Sebire, R D Goldin, L Regan
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 15, 1989
Serum F protein: a new sensitive and specific test of hepatocellular damageG R Foster, R D Goldin, D B Oliveira
Journal of Clinical Pathology|March 28, 1998
A solitary benign lymphoid polyp of the rectum in a 51 year old womanJ Lloyd, A Darzi, J Teare, et al.
Journal of Clinical Pathology|October 1, 1996
Hepatitis C and bile duct lossR D Goldin, N K Patel, H C Thomas
Immunology|October 1, 1985
Quantitative relationship between T3 and the T-cell antigen receptor on a human leukaemic lineR D Goldin, R A Boulton, A W Boylston
Hepatology (Baltimore, Md.)|January 13, 1998
Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosisG R Foster, R D Goldin, H C Thomas
Histopathology|October 2, 2007
Structuring associated with epithelial inclusion cysts following stapled intestinal anastomosisC B B Lim, A Darzi, R D Goldin
European Journal of Immunology|March 1, 1984
A human T cell tumor which expresses the putative T cell antigen receptorA W Boylston, R D Goldin, C S Moore
Hepatology (Baltimore, Md.)|April 16, 1998
Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative StudyG C Farrell, B R Bacon, R D Goldin
Pageof 8